Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Olema Pharmaceuticals
OLMA
$1.03B
| $7.47M | 0.01% |
3,057,306
-3,736,068
| -55% | -$10.9M |
|
777
Altria Group
MO
$113B
| $7.44M | 0.01% |
162,715
-75,887
| -32% | -$3.44M |
|
778
Crinetics Pharmaceuticals
CRNX
$8.85B
| $7.43M | 0.01% |
406,264
+26,568
| +7% | +$468K |
|
|
WBA
779
DELISTED
Walgreens Boots Alliance
WBA
| $7.42M | 0.01% |
198,530
+8,124
| +4% | +$305K |
|
780
Expeditors International
EXPD
$21.8B
| $7.33M | 0.01% |
70,515
+32,103
| +84% | +$3.31M |
|
781
Cincinnati Financial
CINF
$26.8B
| $7.3M | 0.01% |
71,333
+29,303
| +70% | +$3.02M |
|
782
Sight Sciences
SGHT
$286M
| $7.28M | 0.01% |
596,139
-1,002,967
| -63% | -$9.54M |
|
783
DuPont de Nemours
DD
$18.7B
| $7.27M | 0.01% |
84,430
-20,360
| -19% | -$1.63M |
|
|
NUVL
784
DELISTED
Nuvalent
NUVL
| $7.24M | 0.01% |
243,415
-553,897
| -69% | -$15.4M |
|
|
BNY
785
Bank of New York Mellon
BNY
$106B
| $7.12M | 0.01% |
156,435
-218,959
| -58% | -$9.39M |
|
786
Fair Isaac
FICO
$24.6B
| $7.1M | 0.01% |
11,865
-12,815
| -52% | -$6.74M |
|
787
Scotiabank
BNS
$107B
| $7.05M | 0.01% |
144,110
-373,084
| -72% | -$18.4M |
|
788
Charter Communications
CHTR
$16.9B
| $7.03M | 0.01% |
20,732
-6,882
| -25% | -$2.42M |
|
789
Berkshire Hathaway Class A
BRK.A
$1.1T
| $7.02M | 0.01% |
15
+2
| +15% | +$898K |
|
790
IDEX
IEX
$17.2B
| $6.98M | 0.01% |
30,560
+22,860
| +297% | +$5.11M |
|
791
Kimco Realty
KIM
$17.2B
| $6.92M | ﹤0.01% |
326,862
-87,088
| -21% | -$1.83M |
|
792
Arthur J. Gallagher & Co
AJG
$65.9B
| $6.9M | ﹤0.01% |
36,558
-19,176
| -34% | -$3.59M |
|
793
HCA Healthcare
HCA
$85.7B
| $6.89M | ﹤0.01% |
28,696
-69,258
| -71% | -$15.5M |
|
794
Factset
FDS
$9.35B
| $6.88M | ﹤0.01% |
17,144
+14,238
| +490% | +$6.06M |
|
795
Carrier Global
CARR
$50.6B
| $6.87M | ﹤0.01% |
166,451
-76,559
| -32% | -$3.11M |
|
796
Bank OZK
OZK
$5.57B
| $6.84M | ﹤0.01% |
170,841
-86,623
| -34% | -$3.72M |
|
797
Canadian Imperial Bank of Commerce
CM
$108B
| $6.83M | ﹤0.01% |
169,072
-458,536
| -73% | -$20.2M |
|
798
American International
AIG
$41.8B
| $6.77M | ﹤0.01% |
106,988
-91,292
| -46% | -$5.31M |
|
799
Micron Technology
MU
$988B
| $6.75M | ﹤0.01% |
135,067
-135,175
| -50% | -$7.4M |
|
800
McKesson
MCK
$101B
| $6.68M | ﹤0.01% |
17,804
-17,806
| -50% | -$6.64M |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.